George Jurcic
Head of Investor Relations at Lexaria Bioscience | Calgary, Alberta, Canada
George Jurcic’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Head of Investor Relations at Lexaria Bioscience in May 2021 - Present
President at CannaBuild Partners in August 2019 - May 2021
Director Corporate Development at RMMI Corp. in July 2018 - August 2019
Brock University, Bachelor of Business Administration - BBA, January 2002 to January 2006
CFA Institute, January 2010 to January 2014
DehydraTECH™ is Lexaria's patented drug delivery formulation and processing platform technology which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio and many patents pending worldwide. For more information, please visit www.lexariabioscience.com.
Discover more about Lexaria BioscienceWhat is George Jurcic email address?
Email George Jurcic at [email protected]. This email is the most updated George Jurcic's email found in 2026.
How to contact George Jurcic?
To contact George Jurcic send an email to [email protected].
What company does George Jurcic work for?
George Jurcic works for Lexaria Bioscience.
What is George Jurcic's role at Lexaria Bioscience?
George Jurcic is Head of Investor Relations
What industry does George Jurcic work in?
George Jurcic works in the Commercial Real Estate industry.